Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study

被引：20
|
作者：
Michallet, Mauricette [1 ]
Sobh, Mohamad [1 ]
Garban, Frederic [2 ]
Bulabois, Claude Eric [2 ]
Yakoub-Agha, Ibrahim [3 ]
Coiteux, Valerie [3 ]
Dulery, Remy [3 ]
Rohrlich, Pierre-Simon [4 ]
Legrand, Faezeh [4 ]
Clement, Laurence [5 ]
Praire, Aline [1 ]
Detrait, Marie [1 ]
Barraco, Fiorenza [1 ]
Nicolini, Franck Emmanuel [1 ]
Hequet, Olivier [6 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Dept 1G, Pierre Benite, France
[2] CHU Grenoble, Hematol Dept, Grenoble, France
[3] CHRU Lille, Hop Claude Huriez, Serv Malad Sang, Lille, France
[4] CHU Nice, Hematol Dept, Nice, France
[5] CHU Nancy, Nancy, France
[6] Ctr Hosp Lyon Sud, Blood Bank Ctr, Pierre Benite, France
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 02期
关键词：
Extracorporeal photopheresis; GVHD; Allo-HSCT; VERSUS-HOST-DISEASE; ANTITHYMOCYTE GLOBULINS PRIOR; MARROW-TRANSPLANTATION; INTRAVENOUS BUSULFAN; PERIPHERAL-BLOOD; FREE SURVIVAL; T-CELLS; PHOTOCHEMOTHERAPY; REGIMEN; INDUCTION;
D O I：
10.1080/10428194.2017.1334120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We performed a prospective multicenter phase 2 study to evaluate the safety and efficacy of prophylactic Extracorporeal Photopheresis (ECP) in adult patients with hematological malignancies early after RIC allo-HSCT on day 21 twice per week during the first two weeks and then once per week for the next four weeks for a total of eight ECP courses. A total of 20 patients were included; 10 were males, median age was 60 years. All patients engrafted, 17 (85%) received the total eight ECP courses. There were no adverse effects related to ECP. Seven patients developed acute graft-versus-host disease (GVHD), with 15% grade II cumulative incidence at day 100. The cumulative incidence of chronic GVHD at 2 years was 22%. The 2 years probability of overall survival (OS) and progression-free survival (PFS) were 84 and 74%, respectively. This study shows encouraging results with low acute and chronic GVHD incidence and no interference with graft-versus-leukemia (GVL) effect.
引用
收藏
页码：372 / 380
页数：9
相关论文
共 50 条
  • [1] Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
    Shaughnessy, P. J.
    Bolwell, B. J.
    van Besien, K.
    Mistrik, M.
    Grigg, A.
    Dodds, A.
    Prince, H. M.
    Durrant, S.
    Ilhan, O.
    Parenti, D.
    Gallo, J.
    Foss, F.
    Apperley, J.
    Zhang, M-J
    Horowitz, M. M.
    Abhyankar, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 (06) : 1068 - 1076
  • [2] Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis
    Nakamura, Ryotaro
    Forman, Stephen J.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 407 - 421
  • [3] Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning
    Servais, Sophie
    Baron, Frederic
    Beguin, Yves
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 44 (02) : 205 - 210
  • [4] GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study
    Parody, R.
    Lopez-Corral, L.
    Lopez-Godino, O.
    Martinez, C.
    Martino, R.
    Solano, C.
    Barba, P.
    Caballero, D.
    Garcia-Cadenas, I.
    Pinana, J. L.
    Marquez-Malaver, F. J.
    Vazquez, L.
    Esquirol, A.
    Boluda, J. C. H.
    Sanchez-Guijo, F.
    Perez-Simon, J. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1524 - 1526
  • [5] Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
    P J Shaughnessy
    B J Bolwell
    K van Besien
    M Mistrik
    A Grigg
    A Dodds
    H M Prince
    S Durrant
    O Ilhan
    D Parenti
    J Gallo
    F Foss
    J Apperley
    M-J Zhang
    M M Horowitz
    S Abhyankar
    Bone Marrow Transplantation, 2010, 45 : 1068 - 1076
  • [6] Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
    Szyska, Martin
    Na, Il-Kang
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [7] GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresis
    Farid, Kiavasch Mohammad Nejad
    Bug, Gesine
    Schmitt, Anita
    Lang, Fabian
    Schubert, Maria-Luisa
    Haberkorn, Uwe
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Mucositis after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation
    Busemann, Christoph
    Wilfert, Hanna
    Neumann, Thomas
    Kiefer, Thomas
    Doelken, Gottfried
    Krueger, William H.
    ONKOLOGIE, 2011, 34 (10): : 518 - 524
  • [9] Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD
    Bethge, W. A.
    Kerbauy, F. R.
    Santos, E. B.
    Gooley, T.
    Storb, R.
    Sandmaier, B. M.
    BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1198 - 1204
  • [10] The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation
    Hashmi, Shahrukh
    Oliva, Jamie L.
    Liesveld, Jane L.
    Phillips, Gordon L., II
    Milner, Laurie
    Becker, Michael W.
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1052 - 1056
12345